Company: XAIR
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021561
Chunk: 38

Company: Beyond Air, Inc.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 38
---
, and administrative 
     (9,704) 
     (4,698) 
     -  
     (14,402)
  
    Loss from operations 
     (18,630) 
     (7,782) 
     -  
     (26,412)
  
    Interest and finance expense 
     (1,891) 
     -  
     -  
     (1,891)
  
    Other non-operating income/(expense) 
     1,061  
     159  
     -  
     1,220 
  
    Net loss before income taxes 
    $(19,460) 
    $(7,623) 
    $-  
    $(27,083)
  
    Operating activities included in net loss: 

    Depreciation and amortization 
    $1,533  
    $37  
    $-  
    $1,570 
  
    Stock-based compensation expense 
    $3,743  
    $2,765  
    $-  
    $6,508 

    Cash used in operations 
    $(18,482) 
    $(5,047) 
    $-  
    $(23,528)
  
    Cash used in investing 
     14,315  
     4,946  
     -  
     19,261 
  
    Cash from (used in) from investing 
     14,315  
     4,946  
     -  
     19,261 

    Cash from financing 
     21,360  
     -  
     -  
     21,360 
  
    Impact of exchange rates 
     (42) 
     19  
     -  
     (23)
  
    Net change for the period 
    $17,151  
    $(82) 
    $-  
    $17,069 

The
following table summarizes financial information by business segment at September 30, 2025:

    (in thousands) 
    Beyond Air  
    Beyond Cancer  
    NeuroNos  
    Total 
  
    Cash, cash equivalents and marketable securities 
    $7,765  
    $1,503  
    $1,427  
    $10,695 
  
    All